AstraZeneca PLC against Gilead Sciences — live side-by-side technical comparison.
Prices as of 2026-11-11T14:30:11+00:00 UTC · updates daily
GILD leads 5 of the 6 windows we measure — over 1 month AZN is +16.1% and GILD +13.0%; over year to date AZN is -0.0% and GILD +39.2%. The AZN/GILD price ratio stands at 1.093, above its 50-day average of 1.0876, and below the 200-day average of 1.2831. A ratio above its own average means AZN is gaining on GILD; the ratio has barely moved, so neither has an edge on this measure.
Compare AZN and GILD: which has been stronger over the last year, and where does each stand against its 200-day average?Ask the analyst about this pair →
| AZN | GILD | |
|---|---|---|
| Price | $183.80 | $170.87 |
| 1 day | -1.6% | +0.9%lead |
| 5 days | -2.8% | +2.0%lead |
| 1 month | +16.1%lead | +13.0% |
| 6 months | +1.1% | +30.1%lead |
| Year to date | -0.0% | +39.2%lead |
| 1 year | +5.1% | +44.6%lead |
| 2 years | — | +76.9% |
| 52-week position | 51% of range | 90% of range |
| 52-week range | $153.41–$212.71 | $116.88–$176.58 |
| vs 50-day average | above $167.92 | above $154.00 |
| vs 200-day average | above $180.19 | above $141.29 |
| RSI (14) | 61 | 64 |
| Market cap | — | $211.9B |
| Analyst target | — | $174.77 (+2.3%) |
| Analysts | — | 26 |
| Consensus | — | Buy |
| Next earnings | Oct 30, 2026 | Oct 29, 2026 |
AZN trades at $183.80, above its 50-day average of $167.92, and above the 200-day at $180.19. It sits at 51% of its 52-week range ($153.41–$212.71); 14-day RSI is 61, in neutral territory; an average session moves it about 2.7%. For levels, the first level overhead is $187.12 (1.8% away) and the first support below is $183.01 (0.4% down). On the checklist the page runs for every asset, 4 of 6 checks read bullish — the lean is bullish.
GILD trades at $170.87, above its 50-day average of $154.00, and above the 200-day at $141.29. It sits at 90% of its 52-week range ($116.88–$176.58); 14-day RSI is 64, in neutral territory; an average session moves it about 3.2%. For levels, the first level overhead is $174.48 (2.1% away) and the first support below is $154.00 (9.9% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.
GILD is the more volatile of the two — an average session moves it 3.2% against 2.7% for AZN, so an identical position size carries roughly 1.2× the daily risk.
The comparison turns on those levels: AZN clearing $187.12 or losing $183.01; GILD clearing $174.48 or losing $154.00. Until one of them gives way, the relative reading above stands.